Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 513

Similar articles for PubMed (Select 11694102)

1.

Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis.

Ladabaum U, Chopra CL, Huang G, Scheiman JM, Chernew ME, Fendrick AM.

Ann Intern Med. 2001 Nov 6;135(9):769-81.

PMID:
11694102
2.

Cost-effectiveness of colonoscopy in screening for colorectal cancer.

Sonnenberg A, Delcò F, Inadomi JM.

Ann Intern Med. 2000 Oct 17;133(8):573-84.

PMID:
11033584
3.

Summaries for patients. Is aspirin a cost-effective addition to colorectal cancer screening?

[No authors listed]

Ann Intern Med. 2001 Nov 6;135(9):1. No abstract available.

PMID:
11759636
4.

Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis.

Suleiman S, Rex DK, Sonnenberg A.

Gastroenterology. 2002 Jan;122(1):78-84.

PMID:
11781283
5.

Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.

Tsoi KK, Ng SS, Leung MC, Sung JJ.

Aliment Pharmacol Ther. 2008 Aug 1;28(3):353-63. doi: 10.1111/j.1365-2036.2008.03726.x.

PMID:
18638075
6.

Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.

Sharaf RN, Ladabaum U.

Am J Gastroenterol. 2013 Jan;108(1):120-32. doi: 10.1038/ajg.2012.380. Epub 2012 Dec 18.

PMID:
23247579
7.
8.

Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.

Song K, Fendrick AM, Ladabaum U.

Gastroenterology. 2004 May;126(5):1270-9.

PMID:
15131787
9.

Cost effectiveness and projected national impact of colorectal cancer screening in France.

Hassan C, Benamouzig R, Spada C, Ponchon T, Zullo A, Saurin JC, Costamagna G.

Endoscopy. 2011 Sep;43(9):780-93. doi: 10.1055/s-0030-1256409. Epub 2011 May 27.

PMID:
21623557
10.
11.

Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis.

DuPont AW, Arguedas MR, Wilcox CM.

Aliment Pharmacol Ther. 2007 Aug 1;26(3):431-41. Review.

12.

Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.

Vijan S, Hwang EW, Hofer TP, Hayward RA.

Am J Med. 2001 Dec 1;111(8):593-601.

PMID:
11755501
13.

Cost-effectiveness of screening for colorectal cancer in the general population.

Frazier AL, Colditz GA, Fuchs CS, Kuntz KM.

JAMA. 2000 Oct 18;284(15):1954-61.

PMID:
11035892
14.

Cost-effectiveness of screening the average-risk population for colorectal cancer.

Provenzale D.

Gastrointest Endosc Clin N Am. 2002 Jan;12(1):93-109.

PMID:
11916165
15.

Cost effectiveness of colorectal cancer screening in the elderly.

Wagner JL, Herdman RC, Wadhwa S.

Ann Intern Med. 1991 Nov 15;115(10):807-17.

PMID:
1929029
16.

Initial evaluation of rectal bleeding in young persons: a cost-effectiveness analysis.

Lewis JD, Brown A, Localio AR, Schwartz JS.

Ann Intern Med. 2002 Jan 15;136(2):99-110.

PMID:
11790061
17.

Estimates of costs and effects of screening for colorectal cancer in the United States.

Byers T, Gorsky R.

Cancer. 1992 Sep 1;70(5 Suppl):1288-95.

PMID:
1387342
18.

Cost-effectiveness analysis of fecal occult blood screening for colorectal cancer.

Lejeune C, Arveux P, Dancourt V, Béjean S, Bonithon-Kopp C, Faivre J.

Int J Technol Assess Health Care. 2004 Fall;20(4):434-9.

PMID:
15609792
20.

Cost-effectiveness in the prevention of colorectal cancer.

Sonnenberg A.

Gastroenterol Clin North Am. 2002 Dec;31(4):1069-91. Review.

PMID:
12489279
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk